SANOFI-ADR (SNY) Stock Fundamental Analysis
NASDAQ:SNY - Nasdaq - US80105N1054 - ADR - Currency: USD
SNY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 195 industry peers in the Pharmaceuticals industry. SNY scores excellent on profitability, but there are some minor concerns on its financial health. SNY is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
SNY had positive earnings in the past year.
In the past year SNY had a positive cash flow from operations.
In the past 5 years SNY has always been profitable.
Each year in the past 5 years SNY had a positive operating cash flow.
1.2 Ratios
SNY has a better Return On Assets (7.77%) than 91.79% of its industry peers.
SNY's Return On Equity of 13.83% is amongst the best of the industry. SNY outperforms 89.23% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.31%, SNY belongs to the top of the industry, outperforming 90.26% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SNY is significantly below the industry average of 14.70%.
The last Return On Invested Capital (13.31%) for SNY is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 13.83% | ||
| ROIC | 13.31% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
SNY has a Profit Margin of 14.84%. This is amongst the best in the industry. SNY outperforms 90.77% of its industry peers.
In the last couple of years the Profit Margin of SNY has grown nicely.
SNY has a Operating Margin of 23.19%. This is amongst the best in the industry. SNY outperforms 89.74% of its industry peers.
In the last couple of years the Operating Margin of SNY has grown nicely.
SNY's Gross Margin of 70.78% is fine compared to the rest of the industry. SNY outperforms 78.46% of its industry peers.
SNY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.19% | ||
| PM (TTM) | 14.84% | ||
| GM | 70.78% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNY is creating value.
Compared to 1 year ago, SNY has about the same amount of shares outstanding.
The number of shares outstanding for SNY remains at a similar level compared to 5 years ago.
Compared to 1 year ago, SNY has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of SNY is 2.72, which is a good value as it means it would take SNY, 2.72 years of fcf income to pay off all of its debts.
SNY has a better Debt to FCF ratio (2.72) than 91.28% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that SNY is not too dependend on debt financing.
SNY has a Debt to Equity ratio of 0.18. This is comparable to the rest of the industry: SNY outperforms 45.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.72 | ||
| Altman-Z | N/A |
ROIC/WACC1.84
WACC7.24%
2.3 Liquidity
A Current Ratio of 1.37 indicates that SNY should not have too much problems paying its short term obligations.
SNY has a worse Current ratio (1.37) than 73.85% of its industry peers.
A Quick Ratio of 0.69 indicates that SNY may have some problems paying its short term obligations.
SNY's Quick ratio of 0.69 is on the low side compared to the rest of the industry. SNY is outperformed by 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
The earnings per share for SNY have decreased by -0.52% in the last year.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
Looking at the last year, SNY shows a small growth in Revenue. The Revenue has grown by 5.52% in the last year.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
3.2 Future
SNY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.99% yearly.
The Revenue is expected to grow by 4.75% on average over the next years.
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.99%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.75%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.06 indicates a reasonable valuation of SNY.
Based on the Price/Earnings ratio, SNY is valued cheaply inside the industry as 89.74% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.31, SNY is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.32, the valuation of SNY can be described as very reasonable.
Based on the Price/Forward Earnings ratio, SNY is valued cheaply inside the industry as 83.59% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, SNY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.06 | ||
| Fwd PE | 9.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SNY is valued cheaper than 94.87% of the companies in the same industry.
87.69% of the companies in the same industry are more expensive than SNY, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.57 | ||
| EV/EBITDA | 6.02 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SNY has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.32
PEG (5Y)2.17
EPS Next 2Y9.02%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
SNY has a Yearly Dividend Yield of 2.60%.
SNY's Dividend Yield is rather good when compared to the industry average which is at 3.97. SNY pays more dividend than 93.85% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, SNY has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
5.2 History
The dividend of SNY has a limited annual growth rate of 4.30%.
SNY has paid a dividend for at least 10 years, which is a reliable track record.
SNY has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.3%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
SNY pays out 46.28% of its income as dividend. This is a bit on the high side, but may be sustainable.
SNY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP46.28%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
49.67
-1.16 (-2.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner Change0.57%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap120.88B
Analysts81.38
Price Target65.42 (31.71%)
Short Float %0.17%
Short Ratio1.31
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.6% |
Yearly Dividend2.21
Dividend Growth(5Y)4.3%
DP46.28%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.92%
Min EPS beat(2)-2.18%
Max EPS beat(2)6.02%
EPS beat(4)3
Avg EPS beat(4)5.51%
Min EPS beat(4)-2.18%
Max EPS beat(4)14.5%
EPS beat(8)5
Avg EPS beat(8)2.86%
EPS beat(12)8
Avg EPS beat(12)3.25%
EPS beat(16)12
Avg EPS beat(16)3.85%
Revenue beat(2)0
Avg Revenue beat(2)-2.93%
Min Revenue beat(2)-4.57%
Max Revenue beat(2)-1.3%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.47%
Revenue beat(12)5
Avg Revenue beat(12)18.56%
Revenue beat(16)9
Avg Revenue beat(16)27.88%
PT rev (1m)-3.18%
PT rev (3m)5.66%
EPS NQ rev (1m)0.51%
EPS NQ rev (3m)-4.52%
EPS NY rev (1m)0.59%
EPS NY rev (3m)1.78%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-3.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.06 | ||
| Fwd PE | 9.32 | ||
| P/S | 1.52 | ||
| P/FCF | 13.57 | ||
| P/OCF | 9.61 | ||
| P/B | 1.42 | ||
| P/tB | 10.23 | ||
| EV/EBITDA | 6.02 |
EPS(TTM)4.49
EY9.04%
EPS(NY)5.33
Fwd EY10.73%
FCF(TTM)3.66
FCFY7.37%
OCF(TTM)5.17
OCFY10.41%
SpS32.66
BVpS35.04
TBVpS4.86
PEG (NY)1.32
PEG (5Y)2.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.77% | ||
| ROE | 13.83% | ||
| ROCE | 16.06% | ||
| ROIC | 13.31% | ||
| ROICexc | 14.47% | ||
| ROICexgc | 47.61% | ||
| OM | 23.19% | ||
| PM (TTM) | 14.84% | ||
| GM | 70.78% | ||
| FCFM | 11.2% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-ScoreN/A
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 2.72 | ||
| Debt/EBITDA | 0.68 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 55.78% | ||
| Profit Quality | 75.5% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | N/A |
F-ScoreN/A
WACC7.24%
ROIC/WACC1.84
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.52%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%0.56%
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.99%
Revenue 1Y (TTM)5.52%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-5.44%
Revenue Next Year1.53%
Revenue Next 2Y4.25%
Revenue Next 3Y4.83%
Revenue Next 5Y4.75%
EBIT growth 1Y7.75%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y10.86%
FCF growth 1Y-19.94%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y-11.47%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%